Cytosine Arabinoside With Daunorubicin or Adriamycin for Therapy of Acute Myelocytic Leukemia: A CALGB Study

A randomized comparison of the relative efficacy and toxicity of daunorubicin (DNR) at 30 or 45 mg/sq m or adriamycin (ADM) at 30 mg/sq m, given on the first 3 days of a 7-day continuous infusion of cytosine arabinoside (ara-C) at 100 mg/sq m/day. shows the outcome to be dependent on anthracycline,...

Full description

Saved in:

Bibliographic Details
Published in:	Blood Vol. 60; no. 2; pp. 454 - 462
Main Authors:	Yates, Jerome, Glidewell, Oliver, Wiernik, Peter, Cooper, M.Robert, Steinberg, David, Dosik, Harvey, Levy, Robert, Hoagland, Clark, Henry, Patrick, Gottlieb, Arlan, Cornell, Cornelius, Berenberg, Jeffrey, Hutchison, J.Lawrence, Raich, Peter, Nissen, Nis, Ellison, Rose Ruth, Frelick, Robert, James, G.Watson, Falkson, Geoffrey, Silver, Richard T., Haurani, Farid, Green, Mark, Henderson, Edward, Leone, Louis, Holland, James F.
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01-08-1982
Subjects:	Adolescent Adult Age Factors Aged Child Child, Preschool Colitis, Ulcerative - chemically induced Cytarabine - adverse effects Cytarabine - therapeutic use Daunorubicin - adverse effects Daunorubicin - therapeutic use Dose-Response Relationship, Drug Doxorubicin - adverse effects Doxorubicin - therapeutic use Drug Administration Schedule Drug Therapy, Combination Female Humans Infant Leukemia, Myeloid, Acute - drug therapy Male Middle Aged Stomatitis - chemically induced
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!